About past, present and future of Ukraine

Main Diplomacy — The Ukrainian company InterChem started clinical trials for the treatment of COVID-19

Diplomacy

The Ukrainian company InterChem started clinical trials for the treatment of COVID-19

27 Aug, 2020
218
The Ukrainian company InterChem started clinical trials for the treatment of COVID-19

Share this article


The Ministry of Public Health of Ukraine has approved clinical trials of the effectiveness of "Amiksin", produced by InterChem LLC, based in Odessa, to contrast COVID-19.


The company initiated a clinical trial, as the drug had previously shown efficacy against a number of dangerous viral infections. In addition, the active substance Amiksin - tilorone has antiviral activity against a number of strains of ordinary coronaviruses, which was shown in the course of preclinical studies.

Also, several international research centers have already conducted and continue to conduct tilorone tests for the SARS-CoV-2 coronavirus. According to the company's CEO Anatoly Reder, Amiksin is considered as a potentially effective remedy for COVID-19 not only at InterChem, but also in the research community abroad. Similar studies were conducted at the Pasteur Institute (South Korea), and work is still ongoing at two research centers in the United States.

“Based on the data of preclinical studies demonstrating the antiviral effect of tilorone against SARS-CoV-2, we applied to the Ministry of Health of Ukraine for approval of a phase 3 clinical study to expand the range of use of Amiksin and obtain evidence of its efficacy and safety for treating patients with COVID-19.

Anatoliy Reder, CEO of InterChem LLC

Clinical trials of Amiksin will be carried out by research centers in three cities of Ukraine, in general, it may take 3-4 months from the date of receipt of permission from the Ministry of Health to conduct it.

The duration of the study will primarily depend on the speed of patient recruitment. At this stage, it is planned to include more than 60 volunteers in the study, who, according to the severity of the disease, will be on self-isolation and undergo outpatient treatment.

Anatoliy Reder, CEO of InterChem LLC

According to him, the research doctors who confirmed their readiness to conduct this study are highly motivated, first of all, by their scientific interest and the opportunity to contribute to the search for a solution to the medical and social problem that has become so urgent for the whole world, which the new coronavirus has become.


Source: InterChem LLC

The Odessa Journal

The Odessa Journal

more articles

Top article

The Ministry of Defense has signed a contract for the construction of a service center for repairing drones in Ukraine
War

The Ministry of Defense has signed a contract ...

Dmytro Kuleba: Ukraine and Croatia have agreed to use Croatian ports for exporting Ukrainian grain
Business

Dmytro Kuleba: Ukraine and Croatia have agree ...

New sanctions: Defence industry, political parties and individuals linked to oligarchs
Business

New sanctions: Defence industry, political pa ...

Volodymyr Zelensky: We are preparing for the next Ramstein meeting, we expect solidly grounded decisions to meet the prospects on the battlefield
War

Volodymyr Zelensky: We are preparing for the ...